Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Determining Outcome in IgM Gammopathies: Integration of Molecular, Flow Cytometry and Clinical Factors in an International, Multicenter Series (the SAL-TO Study)

Blood (2024) 144 (Supplement 1): 4390.

https://doi.org/10.1182/blood-2024-197940

Published: 2024

Journal Articles

Predictive Value of Interim and End of Treatment PET/CT in Front-Line Treatment of Peripheral T-Cell Lymphoma

Nicolo Rampi, Belen Hervas Sanz, Carolina Esther Arevalo Leon, Angelo Castellani, Patricia Lopez Pereira, Elena Bechtold Javier, Ana C de Oliveira, Sara Pacella, Carmen Aguilera, Anna Valer, Eva Gonzalez Barca, Francesca Gaia Rossi, Carolina Martinez-Ramos, Ana Maria Sureda Balari, Montserrat Cortes-Romera, Eva Domingo Domenech

Blood (2024) 144 (Supplement 1): 6417.

https://doi.org/10.1182/blood-2024-210108

Published: 2024

Journal Articles

Comprehensive Geriatric Assessment in Diffuse Large B-Cell Lymphomas Patients Older Than 70 Years Old: Prospective Single-Center Experience

Nicolo Rampi, Maite Antonio, Eva Domingo Domenech, Patricia Lopez-Pereira, Ana C. De Oliveira, Carmen Aguilera, Anna Maria Sureda Balari, Eva Maria Gonzalez Barca

Blood (2023) 142 (Supplement 1): 6280.

https://doi.org/10.1182/blood-2023-190136

Published: 2023

Journal Articles

Neurofilaments As Serum Biomarkers of Brentuximabvedotin-Induced Peripheral Neurotoxicity in CD30 + Lymphoma Patients: A Prospective Single-Center Study

Eva Domingo Domenech, Carla Marco, Eva Maria Gonzalez Barca, Cristina Muniesa, Patricia Lopez-Pereira, Ana C. De Oliveira, Carmen Aguilera, German Ferrer, Anna Maria Sureda Balari, Roser Velasco

Blood (2023) 142 (Supplement 1): 6186.

https://doi.org/10.1182/blood-2023-182348

Published: 2023

Journal Articles

Prospective Assessment of Motor Neurotoxicity and Sarcopenia in CD30+ Lymphoma Patients Treated with Brentuximab Vedotin. Single Center Multidisciplinary Unit Experience

Domingo Domenech Eva, Marta Bellver, German Ferrer, Eva Gonzalez Barca, Itziar Carro, Ana C Oliveira, Patricia Lopez, Gabriela Sanz-Linares, Carmen Aguilera, Montserrat Alemany, Inmaculada Peiro, Anna Sureda, Roser Velasco

Blood (2022) 140 (Supplement 1): 9420–9421.

https://doi.org/10.1182/blood-2022-165345

Published: 2022

Journal Articles

Role of High-Dose Melphalan and Autologous Stem Cell Transplantation in Multiple Myeloma Patients Presenting with t(11;14)

Blood (2019) 134 (Supplement_1): 4580.

https://doi.org/10.1182/blood-2019-129880

Published: 2019

Journal Articles

Validation of the NCCN-IPI and the Geltamo-IPI in a Large Cohort of Patients Diagnosed of Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP/R-CHOP-like in a Single Institution

Maria Queralt Salas Gay, MD, Santiago Mercadal, MD, Eva Domingo Domenech, MD, Ana C Oliveira, MD PhD, Maite Encuentra, Fina Climent, MD PhD, Cristina Baca Cano, MD, Marcio Andrade-Campos, MD PhD, Esmeralda De la Banda, MD, Carmen Aguilera, Alberto Fernandez de Sevilla, MD PhD, Anna Sureda, Eva González-Barca, MD PhD

Blood (2017) 130 (Supplement 1): 4151.

https://doi.org/10.1182/blood.V130.Suppl_1.4151.4151

Published: 2017

Journal Articles

Abnormal Karyotype (Not Only Complex) at Diagnosis Is an Independent Prognostic Factor for Overall Survival in Early Stage Chronic Lymphocytic Leukemia Patients. Results of a Prospective Study with a Median Follow-up of More Than 7-Years

Ana C Oliveira, MD PhD, Esmeralda De la Banda, MD, Eva Domingo Domenech, MD, Isabel Granada, PhD, Alberto Fernandez de Sevilla, MD PhD, Santiago Mercadal, MD, Marcio Andrade-Campos, MD PhD, Maite Encuentra, Carmen Aguilera, Anna Sureda, Eva González-Barca, MD PhD

Blood (2017) 130 (Supplement 1): 5142.

https://doi.org/10.1182/blood.V130.Suppl_1.5142.5142

Published: 2017

Journal Articles

Treatment of Primary Cutaneous Marginal Zone B-Cell Lymphomas with Intralesional Rituximab

Eva Domingo Domenech, MD, Queralt Salas, MD, Octavio Servitje, MD PhD, Fina Climent, MD PhD, Helena Pomares, Ana Lucas, MD, Carmen Aguilera, Mrs, Alessandra Comai, Santiago Mercadal, MD, Eva Gonzalez Barca, PhD, Anna Sureda, MD PhD

Blood (2016) 128 (22): 1796.

https://doi.org/10.1182/blood.V128.22.1796.1796

Published: 2016

Journal Articles

CD30 Expression in Diffuse Large B-Cell Lymphoma (DLBCL) Correlates with Non-GCB Subtype but Does Not Have Prognostic Impact in Patients Treated with First Line R-CHOP/R-CHOP-like

Maria Queralt Salas, MD, Fina Climent, PhD, Eva Domingo Domenech, MD, Santiago Mercadal, MD, Viviana Paredes, MD, Ana Carla Oliveira, PhD, Carmen Aguilera, Mrs, Esmeralda de la Banda, MD, Anna Lucas, MD, Nadia Garcia, MD, Cristina Baca, MD, Alberto Fernandez de Sevilla, MD PhD, Anna Sureda, MD PhD, Eva Gonzalez Barca, PhD, Maria Lutgarda Riasol

Blood (2016) 128 (22): 4209.

https://doi.org/10.1182/blood.V128.22.4209.4209

Published: 2016

Journal Articles

Immunoparesis Recovery As Predictor Marker of Progression after Autologous Stem Cell Transplantation in Multiple Myeloma

Blood (2015) 126 (23): 4356.

https://doi.org/10.1182/blood.V126.23.4356.4356

Published: 2015

Journal Articles

A New Multiple Single-Nucleotide Polymorphisms Based Predictive Model for Grades III to IV and Extensive Graft Versus Host Disease after Identical HLA-Allogeneic Stem-Cell

Blood (2015) 126 (23): 921.

https://doi.org/10.1182/blood.V126.23.921.921

Published: 2015

Journal Articles

Primary Cutaneous Marginal Zone B-Cell Lymphoma Treated with Intralesional Rituximab: Experience of a Single Center

Eva Domingo-Domenech, MD, Queralt Salas, MD, Fina Climent, MD PhD, Carmen Aguilera, Mrs, Helena Pomares, MD, Eva González-Barca, MD PhD, Santiago Mercadal, MD, Anna Lucas, MD, Alberto Fernandez de Sevilla, MD PhD, Anna Sureda, MD PhD, Octavio Servitje, MD PhD

Blood (2015) 126 (23): 5087.

https://doi.org/10.1182/blood.V126.23.5087.5087

Published: 2015

Journal Articles

Design and Validate of Next-Generation Sequencing Panel for Inherited Platelet Disorders

Blood (2014) 124 (21): 4210.

https://doi.org/10.1182/blood.V124.21.4210.4210

Published: 2014

Journal Articles

Bence Jones Proteinuria in Smoldering Multiple Myeloma As Predictor Marker of Progression to Symptomatic Multiple Myeloma

Veronica Gonzalez de la Calle, MD, Ramon Garcia-Sanz, Eduardo Sobejano, Enrique M. Ocio, MD PhD, Noemi Puig, MD PhD, Norma Carmen Gutierrez, PhD MD, Alberto Melón, MD, Joaquin Gonzalez, MD, Alfonso Garcia de Coca, MD, Jose M. Hernandez, MD, Roberto Hernandez, MD, Abelardo Barez, MDPhD, Jose M. Alonso, MD, Carmen Aguilera, MD, Fernando Escalante, Guillermo Martin, MD, Rosa Lopez, MD, Pilar de la Fuente, MD, Maria-Victoria Mateos, MD PhD

Blood (2014) 124 (21): 3369.

https://doi.org/10.1182/blood.V124.21.3369.3369

Published: 2014

Journal Articles

6q Deletion Helps in the Discrimination Between Symptomatic Waldenström's Macroglobulinemia and Asymptomatic Forms of IgM Monoclonal Gammopathies

Ramón García-Sanz, Roberto JP Magalhaes, Enrique M Ocio, MD, PhD, Pilar Giraldo, MD, PhD, Natalia de las Heras, Carmen Aguilera, Jose Mariano Hernández, Alfonso Garcia de Coca, Noemi Puig, Ilda Murillo, MD, Elena Sebastian, MD, Marcos González, Jesus F. San Miguel, MD, PhD, Norma Gutierrez

Blood (2012) 120 (21): 4566.

https://doi.org/10.1182/blood.V120.21.4566.4566

Published: 2012

Journal Articles

6q Deletion in Waldenström Macroglobulinemia Is the Most Common Cytogenetic Abnormality and Is Associated with Aggressive Disease with a Trend towards Worse Survival.

Roelandt F.J. Schop, MD, Enrique M. Ocio, MD, Belen Gonzalez, MD, PhD, Norma C. Gutierrez, MD, PhD, Maria Jesus Moro, MD, Carmen Aguilera, MD, Jose Hernández, MD, Ramon García-Sanz, MD, PhD, Ruifang Xu, PhD, Jesus M. Hernandez-Rivas, MD, Ph.D, Philip R. Greipp, MD, Angela Dispenzieri, MD, Syed M. Jalal, PhD, Martha Q. Lacy, MD, Natalia Gonzalez-Paz, MD, Morie A. Gertz, MD, Jesús F. San Miguel, MD, PhD, Rafael Fonseca, MD

Blood (2005) 106 (11): 986.

https://doi.org/10.1182/blood.V106.11.986.986

Published: 2005

Journal Articles

Analysis of Both Clonal Functional and Non-Functional Immunoglobulin Heavy Chain (IgH) Rearrangements in Waldenström’s Macroglobulinemia.

Patricia Martin-Jimenez, Ana Balanzategui, Miguel E. Ocio, Miguel Alcoceba, Maria E. Sarasquete, Carmen Aguilera, Jose A. Portero, Javier Fernandez Calvo, Javier Garcia Frade, Maria C. Chillon, Guadalupe Diaz, Adriana Armellini, Ramon Garcia-Sanz, Marcos Gonzalez, J.F. San Miguel

Blood (2005) 106 (11): 4334.

https://doi.org/10.1182/blood.V106.11.4334.4334

Published: 2005

NARROW

Determining Outcome in IgM Gammopathies: Integration of Molecular, Flow Cytometry and Clinical Factors in an International, Multicenter Series (the SAL-TO Study)

Predictive Value of Interim and End of Treatment PET/CT in Front-Line Treatment of Peripheral T-Cell Lymphoma

Comprehensive Geriatric Assessment in Diffuse Large B-Cell Lymphomas Patients Older Than 70 Years Old: Prospective Single-Center Experience

Neurofilaments As Serum Biomarkers of Brentuximabvedotin-Induced Peripheral Neurotoxicity in CD30 + Lymphoma Patients: A Prospective Single-Center Study

Prospective Assessment of Motor Neurotoxicity and Sarcopenia in CD30+ Lymphoma Patients Treated with Brentuximab Vedotin. Single Center Multidisciplinary Unit Experience

Role of High-Dose Melphalan and Autologous Stem Cell Transplantation in Multiple Myeloma Patients Presenting with t(11;14)

Validation of the NCCN-IPI and the Geltamo-IPI in a Large Cohort of Patients Diagnosed of Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP/R-CHOP-like in a Single Institution

Abnormal Karyotype (Not Only Complex) at Diagnosis Is an Independent Prognostic Factor for Overall Survival in Early Stage Chronic Lymphocytic Leukemia Patients. Results of a Prospective Study with a Median Follow-up of More Than 7-Years

Treatment of Primary Cutaneous Marginal Zone B-Cell Lymphomas with Intralesional Rituximab

CD30 Expression in Diffuse Large B-Cell Lymphoma (DLBCL) Correlates with Non-GCB Subtype but Does Not Have Prognostic Impact in Patients Treated with First Line R-CHOP/R-CHOP-like

Immunoparesis Recovery As Predictor Marker of Progression after Autologous Stem Cell Transplantation in Multiple Myeloma

A New Multiple Single-Nucleotide Polymorphisms Based Predictive Model for Grades III to IV and Extensive Graft Versus Host Disease after Identical HLA-Allogeneic Stem-Cell

Primary Cutaneous Marginal Zone B-Cell Lymphoma Treated with Intralesional Rituximab: Experience of a Single Center

Design and Validate of Next-Generation Sequencing Panel for Inherited Platelet Disorders

Bence Jones Proteinuria in Smoldering Multiple Myeloma As Predictor Marker of Progression to Symptomatic Multiple Myeloma

6q Deletion Helps in the Discrimination Between Symptomatic Waldenström's Macroglobulinemia and Asymptomatic Forms of IgM Monoclonal Gammopathies

6q Deletion in Waldenström Macroglobulinemia Is the Most Common Cytogenetic Abnormality and Is Associated with Aggressive Disease with a Trend towards Worse Survival.

Analysis of Both Clonal Functional and Non-Functional Immunoglobulin Heavy Chain (IgH) Rearrangements in Waldenström’s Macroglobulinemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only